Abstract
Human neutrophil elastase (HNE) is involved in the degradation of matrix proteins playing an important role in inflammation modulation. In this study, a microemulsion (ME) containing a new human neutrophil elastase inhibitor was developed and characterized in terms of pH, rheology (viscosity and oscillatory experiments) and drug release. This formulation is suitable for topical application to treat inflammatory diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marto, J., Ruivo, E., Lucas, S.D., Gonçalves, L.M., Simões, S., Gouveia, L.F., et al.: Starch nanocapsules containing a novel neutrophil elastase inhibitor with improved pharmaceutical performance. Eur. J. Pharm. 127, 1–11 (2018)
Santana, A.B., Lucas, S.D., Gonçalves, L.M., Correia, H.F., Cardote, T.A.F., Guedes, R.C., et al.: N-Acyl and N-sulfonyloxazolidine-2, 4-diones are pseudo-irreversible inhibitors of serine proteases. Bioorg. Med. Chem. Lett. 22, 3993–3997 (2012)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this paper
Cite this paper
Nunes, A., Marto, J., Lopes, F., Ribeiro, H.M. (2020). HNE Microemulsion: Development, Rheological Characterization and In Vitro Release Studies. In: Galindo-Rosales, F., Campo-Deaño, L., Afonso, A., Alves, M., Pinho, F. (eds) Proceedings of the Iberian Meeting on Rheology (IBEREO 2019). IBEREO 2019. Springer Proceedings in Materials. Springer, Cham. https://doi.org/10.1007/978-3-030-27701-7_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-27701-7_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-27700-0
Online ISBN: 978-3-030-27701-7
eBook Packages: EngineeringEngineering (R0)